ORIGINAL PAPER
Association between Helicobacter pylori infection and cirrhosis in children
1
Paediatric Ward, Medical College, Shiraz University of Medical Sciences, Shiraz, Iran
2
Paediatric Ward, GI Department, Alborz University of Medical Sciences, Karaj, Iran
3
Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
Submission date: 2019-06-03
Final revision date: 2019-09-02
Acceptance date: 2019-09-05
Publication date: 2019-09-30
Medical Studies 2019;35(3):198-202
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Liver cirrhosis is often accompanied by fibrosis, loss of liver function, and liver cancer. Identification of the factors associated with this disease has always been a goal because they can be effective in its treatment. Several reports showed that Helicobacter pylori (H. pylori) can cause multiple gastrointestinal complications.
Aim of the research:
To investigate the association between H. pylori infection and liver cirrhosis in children.
Material and methods:
In this case-control study, 60 children under the age of 18 years with liver cirrhosis participated as the cases, and 236 healthy children were included as controls. For evaluation of the H. pylori antigen (Ag) of the samples, fresh stool samples were prepared.
Results:
Thirty-two (53.3%) samples in the cases, and 46 (19.5%) samples in controls had positive H. pylori Ag test. The results showed that the two groups had significant differences in terms of infection by H. pylori stool antigen; the presence of this Ag in the case samples was more than in the controls (p < 0.001).
Conclusions:
That the rate of H. pylori infection in children with cirrhosis was significantly higher than among healthy children. This result can indicate the effect of this bacterium on the incidence and development of liver cirrhosis.
Liver cirrhosis is often accompanied by fibrosis, loss of liver function, and liver cancer. Identification of the factors associated with this disease has always been a goal because they can be effective in its treatment. Several reports showed that Helicobacter pylori (H. pylori) can cause multiple gastrointestinal complications.
Aim of the research:
To investigate the association between H. pylori infection and liver cirrhosis in children.
Material and methods:
In this case-control study, 60 children under the age of 18 years with liver cirrhosis participated as the cases, and 236 healthy children were included as controls. For evaluation of the H. pylori antigen (Ag) of the samples, fresh stool samples were prepared.
Results:
Thirty-two (53.3%) samples in the cases, and 46 (19.5%) samples in controls had positive H. pylori Ag test. The results showed that the two groups had significant differences in terms of infection by H. pylori stool antigen; the presence of this Ag in the case samples was more than in the controls (p < 0.001).
Conclusions:
That the rate of H. pylori infection in children with cirrhosis was significantly higher than among healthy children. This result can indicate the effect of this bacterium on the incidence and development of liver cirrhosis.
REFERENCES (42)
1.
Zare Marzouni H, Sharaf S, Zarrinkamar M, Shaban S, Aryan H, Saburi E. Thioredoxin reductase activity and its tissue distribution in the pathologic specimens of patients with laryngeal squamous cell carcinoma. Galen Med J 2016; 5: 153-159.
2.
Abbasi Gamasaee N, Radmansouri M, Ghiasvand S, Shahriari F, Marzouni HZ, Aryan H, Jangholi E, Javidi MA. Hypericin induces apoptosis in MDA-MB-175-VII cells in lower dose compared to MDA-MB-231. Arch Iran Med 2018; 21: 387-392.
3.
Bendtsen F, Larsen FS, Ott P, Vilstrup H. Cirrhosis of the liver. Ugeskrift for laeger 2014; 176: 346-349.
4.
Gross M. Liver cirrhosis and the most common complications: diagnosis and treatment. MMW Fortsch Med 2015; 157 Suppl 1: 75-79.
5.
Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008; 47: 729-736.
6.
Ascione T, Di Flumeri G, Boccia G, De Caro F. Infections in patients affected by liver cirrhosis: an update. Infez Med 2017; 25: 91-97.
7.
Leung DH, Narkewicz MR. Cystic fibrosis-related cirrhosis. J Cystic Fibrosis 2017; 16 Suppl 2: S50-S61.
8.
Romanelli RG, Stasi C. Recent advancements in diagnosis and therapy of liver cirrhosis. Curr Drug Targets 2016; 17: 1804-1817.
9.
Pimenta JR, Ferreira AR, Fagundes ED, Queiroz TC, Baptista RA, de Araujo Moreira EG, de Resende CB, Bittencourt PF, Carvalho SD, Neto JA, Penna FJ. Factors associated with bleeding secondary to rupture of esophageal varices in children and adolescents with cirrhosis. J Pediatr Gastroenterol Nutr 2017; 64: e44-e48.
10.
Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, Durmaz O, Lacaille F, McLin V, Nobili V. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2012; 54: 700-713.
11.
Fashner J, Gitu AC. Diagnosis and treatment of peptic ulcer disease and H. pylori infection. Am Fam Phys 2015; 91: 236-242.
12.
Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Investig 1999; 104: R49-R54.
13.
Yakoob MY, Hussainy AS. Chronic gastritis and Helicobacter pylori: a histopathological study of gastric mucosal biopsies. J Coll Physicians Surg Pakistan 2010; 20: 773-775.
14.
Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography. Helicobacter 2015; 20: 239-251.
15.
Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter 2017; 22:doi: 10.1111/hel.12330.
16.
Fallah S, Ahmadi R, Moradi N, Fadaei R, Sezavar SH, Seifi M. Helicobacter pylori infection and iron deficiency in patients with coronary artery disease. Cell Mol Biol 2016; 62: 8-14.
17.
Huang J, Cui J. Evaluation of Helicobacter pylori infection in patients with chronic hepatic disease. Chin Med J 2017; 130: 149-154.
18.
Kountouras J, Deretzi G, Zavos C, Katsinelos P. Helicobacter pylori infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension. Ann Gastroenterol 2014; 27: 285.
19.
Ponzetto A, Figura N. Helicobacter pylori infection among patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2018; 30: 490.
20.
Sun M, Tang X, Sun K, Wang Y, Sun H, Zhou C. Research progress of Helicobacter pylori in the development of hepatitis, cirrhosis and hepatic carcinoma. Clin Med China 2016; 32: 665-667.
21.
Pogorzelska J, Łapińska M, Kalinowska A, Łapiński TW, Flisiak R. Helicobacter pylori infection among patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2017; 29: 1161-1165.
22.
Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci 2013; 14: 851-858.
23.
Laleman W, Simon-Talero M, Maleux G, Perez M, Ameloot K, Soriano G, Villalba J, Garcia-Pagan JC, Barrufet M, Jalan R, Brookes J, Thalassinos E, Burroughs AK, Cordoba J, Nevens F; EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 2013; 57: 2448-2457.
24.
Boonyanugomol W, Chomvarin C, Sripa B, Bhudhisawasdi V, Khuntikeo N, Hahnvajanawong C, Chamsuwan A. Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB 2012; 14: 177-184.
25.
Sakamoto Y, Oho K, Toyonaga A, Kumamoto M, Haruta T, Inoue H, Emori K, Tsuruta O, Sata M. Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension. J Gastroenterol Hepatol 2013; 28: 1444-1449.
26.
Sandulache L, Stanciu C. Prevalence of Helicobacter pylori in liver cirrhosis complicated with hepatic encephalopathy. Rev Med Chir Soc Med Nat Iasi 2009; 113: 1056-1060.
27.
Sathar SA, Kunnathuparambil SG, Sreesh S, Narayanan P, Vinayakumar KR. Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy. Ann Gastroenterol 2014; 27: 48-52.
28.
Xu MH, Qu Q, Zhang GY. H. pylori in patients with cirrhosis and liver cirrhosis with hepatocellular carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2007; 32: 917-920.
29.
Acalovschi M. Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects. World J Gastroenterol 2014; 20: 7277-7285.
30.
Cordova J, Jericho H, Azzam RK. An overview of cirrhosis in children. Pediatr Ann 2016; 45: e427-e432.
31.
Shrestha SM, Shrestha S. Hepatic vena cava syndrome: a common cause of liver cirrhosis in children in Nepal. Trop Gastroenterol 2014; 35: 85-95.
32.
Zhu JA, Hu B. Ultrasonography in predicting and screening liver cirrhosis in children: a preliminary study. World J Gastroenterol 2003; 9: 2348-2349.
33.
Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol 2011; 17: 1237-1248.
34.
Terai S, Tsuchiya A. Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis. J Gastroenterol 2017; 52: 129-140.
35.
Polis S, Fernandez R. Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol. JBI Database System Rev Implement Rep 2015; 13: 39-51.
36.
Casswall TH, Nemeth A, Nilsson I, Wadstrom T, Nilsson HO. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease. Scand J Gastroenterol 2010; 45: 160-167.
37.
Feng H, Zhou X, Zhang G. Association between cirrhosis and Helicobacter pylori infection: a meta-analysis. Eur J Gastroenterol Hepatol 2014; 26: 1309-1319.
38.
Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, Miglioli M, Corinaldesi R, Bolondi L. High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997; 42: 2024-2030.
39.
Kountouras J, Zavos C, Deretzi G. Helicobacter pylori might contribute to persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011; 9: 624-625.
40.
Abdel-Hady H, Zaki A, Badra G, Lotfy M, Selmi C, Giorgini A, El-Sayed M, Badr R. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007; 37: 1026-1033.
41.
Huber M, Rossle M, Siegerstetter V, Ochs A, Haag K, Kist M, Blum HE. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 2001; 48: 541-544.
42.
Zullo A, Rinaldi V, Meddi P, Hassan C, Winn S, Attili AF. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients. Am J Gastroenterol 1999; 94: 2214-2218.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
